2023
Exports
$28.1BWorld Rnk 5 / 208
Flag Rnk 3 / 1216
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$26.3BWorld Rnk 3 / 222
Flag Rnk 3 / 1213
2023
ECONOMIC COMPLEXITY of Belgium
1.23Rnk 20 / 132

About

Exports In 2023, Belgium exported $28.1B in Vaccines, blood, antisera, toxins and cultures, making it the 5th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 3rd most exported product in Belgium. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Belgium are: United States ($5.13B), Germany ($4.24B), France ($2.31B), Italy ($2.13B), and Japan ($1.37B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Belgium between 2022 and 2023 were China ($444M), Netherlands ($160M), and Brunei ($113M).

Imports In 2023, Belgium imported $26.3B in Vaccines, blood, antisera, toxins and cultures, becoming the 3rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 3rd most imported product in Belgium. Belgium imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($7.57B), United States ($6.91B), Switzerland ($5.75B), France ($1.42B), and Germany ($1.27B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Belgium between 2022 and 2023 were United States ($4.4B), Switzerland ($1.69B), and Spain ($893M).

Historical Data

Trade Balance

Color
EXPORTS (2023)$28.1B
IMPORTS (2023)$26.3B
NET TRADE (2023)$1.79B

In 2023, Belgium exported $28.1B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Belgium exports on Vaccines, blood, antisera, toxins and cultures were United States ($5.13B), Germany ($4.24B), France ($2.31B), Italy ($2.13B), and Japan ($1.37B).

In 2023, Belgium imported $26.3B in Vaccines, blood, antisera, toxins and cultures, mainly from Ireland ($7.57B), United States ($6.91B), Switzerland ($5.75B), France ($1.42B), and Germany ($1.27B).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Belgium WERE (2022 - 2023):
China$444M (153%)
Netherlands$160M (18.6%)
Brunei$113M (1.85k%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Belgium WERE (2022 - 2023):
Germany-$4.63B (-52.2%)
Japan-$3.42B (-71.4%)
United States-$3.1B (-37.6%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Belgium's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Belgium's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALGermany+ $2.4B
TOP IMPORT POTENTIALGermany+ $968M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Germany. With an export gap of $2.4B.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $968M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with